Sofosbuvir plus Peginterferon plus Ribavirin for 12 Weeks in Genotype 3 HCV Infected Patients and Treatment-Experienced Cirrhotic Patients with Genotype 2 HCV Who Did Not Achieve SVR after 16 or 24 Weeks of Sofosbuvir plus Ribavirin

  • K Agarwal
  • , M Schultz
  • , S Pianko
  • , L Bank
  • , J Collier
  • , J George
  • , M Priest
  • , SD Ryder
  • , BE Burman
  • , K Cheent
  • , M Cramp
  • , DM Forton
  • , BA Leggett
  • , GC MacQuillan
  • , A Ramji
  • , P Richardson
  • , MJ Ryan
  • , N Stace
  • , A Zekry
  • , DL Zogg
  • E Barnes, DM Brainard, B Massetto, F Chen, JG McHutchison, M Subramanian, EM Yoshida, GR Foster

Research output: Contribution to journalConference proceedings published in a journalpeer-review

Original languageEnglish
Pages (from-to)455A-456A
Number of pages0
JournalHepatology
Volume64
Issue number0
Publication statusPublished - 2016

Cite this